ADC Therapeutics
ADC Therapeutics SA focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product is ZYNLONTA, a CD19-directed ADC, received accelerat...
ADC Therapeutics Logo
About ADC Therapeutics
ADC Therapeutics SA operates as a clinical-stage oncology drug discovery and development company. The Company focuses on advancing highly potent and targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. ADC Therapeutics serves customers in the United States, Switzerland, and the United Kingdom.
Address
BiopOle, Route de la Corniche 3B
Epalinges, 1066
Switzerland
Year founded
2011
Number of employees
200-300
Report inaccurate data
Request an update to help us keep the brand up-to-date.
